Skip to main content
TipRanks
Go Ultimate75% OFF

Vectorite Biomedical, Inc. (4170) Cash flow

Vectorite Biomedical, Inc. Cash Flow

TW:4170's free cash flow for Q2 2026 was NT$-4.88M. For the 2026 fiscal year, TW:4170's free cash flow was decreased by NT$-83.00K and operating cash flow was NT$-4.80M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -5.79MNT$ -11.51MNT$ 1.30MNT$ 14.70MNT$ -65.79M
NT$ 1.34MNT$ 16.36MNT$ -3.82MNT$ -26.34MNT$ -41.67M
NT$ -344.00KNT$ 200.00KNT$ 0.00NT$ 0.00NT$ 118.08M
NT$ 25.71MNT$ 30.60MNT$ 25.32MNT$ 27.87MNT$ 39.20M
NT$ -9.78MNT$ -14.35MNT$ -3.46MNT$ 13.81MNT$ -67.59M

Currency in TWD

Vectorite Biomedical, Inc. Cash Flow

-200M-150M-100M-50M050M100M150M201720182019202020212022202320242025OperatingInvestingFinancing